January 1988
Volume 29, Issue 1
Free
Articles  |   January 1988
Cell culture of the human lamina cribrosa.
Author Affiliations
  • M R Hernandez
    Ophthalmic Pharmacology Unit, Eye Research Institute, Boston, MA 02114.
  • F Igoe
    Ophthalmic Pharmacology Unit, Eye Research Institute, Boston, MA 02114.
  • A H Neufeld
    Ophthalmic Pharmacology Unit, Eye Research Institute, Boston, MA 02114.
Investigative Ophthalmology & Visual Science January 1988, Vol.29, 78-89. doi:
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M R Hernandez, F Igoe, A H Neufeld; Cell culture of the human lamina cribrosa.. Invest. Ophthalmol. Vis. Sci. 1988;29(1):78-89.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
This content is PDF only. Please click on the PDF icon to access.
Abstract

The extracellular matrix of the lamina cribrosa may be important in the changes in the optic nerve head associated with glaucoma. To investigate the cell biology of this tissue, human lamina cribrosa was explanted in tissue culture and two cell types grown from this tissue were characterized. The most common cell type obtained was a large, flat, polygonal cell which was negative for glial fibrillar acidic protein (GFAP) and could be serially subcultured. This cell type synthesized collagens type III and type IV, fibronectin and elastin. Much less commonly grown was a cell type with conspicuous long processes and which was positive for GFAP. This presumed astrocyte synthesized collagen type IV and fibronectin. Fibroblastic cells were not obtained from this tissue but were easily grown from sclera. The cells that we have cultured from the human lamina cribrosa may produce the extracellular matrix present in the cribriform plates of this tissue and be important in the glaucomatous process.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×